D. E. Shaw & Co., Inc. Emergent Bio Solutions Inc. Transaction History
D. E. Shaw & Co., Inc.
- $156 Billion
- Q3 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 321,167 shares of EBS stock, worth $3.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
321,167
Previous 411,368
21.93%
Holding current value
$3.25 Million
Previous $2.62 Million
7.93%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding EBS
# of Institutions
193Shares Held
41.5MCall Options Held
901KPut Options Held
245K-
Black Rock Inc. New York, NY3.84MShares$38.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$36.5 Million3.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$35.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.45MShares$24.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$24.1 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $504M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...